Literature DB >> 25142886

We need both randomized trials and real-world data: the example of everolimus as second-line therapy for mRCC.

Mimma Rizzo1, Giacomo Cartenì, Giovanni Pappagallo.   

Abstract

Entities:  

Keywords:  everolimus; mRCC; observational studies; randomized trials; second-line therapy

Mesh：

Substances：

Year:  2014        PMID： 25142886     DOI： 10.2217/fon.14.182

Source DB:  PubMed          Journal:  Future Oncol        ISSN： 1479-6694            Impact factor:   3.404


× No keyword cloud information.
  5 in total

1.  Eribulin in "Field Practice": More from the Italian Experience.

Authors:  Giulia Valeria Bianchi
Journal:  Oncology       Date:  2018-07-23       Impact factor: 2.935

2.  Eribulin in Male Patients With Breast Cancer: The First Report of Clinical Outcomes.

Authors:  Francesco Giotta; Luigi Acito; Giampiero Candeloro; Pietro Del Medico; Gennaro Gadaleta-Caldarola; Guido Giordano; Rossana Gueli; Antonio Lugini; Valentina Magri; Marta Mandarà; Giovanna Masci; Salvatore Pisconti; Mirco Pistelli; Anna Rizzi; Nello Salesi; Alessio Schirone; Giovanni Scognamiglio; Maria Tedeschi; Patrizia Zucchinelli
Journal:  Oncologist       Date:  2016-10-14

Review 3.  Clinical experience with everolimus in the second-line treatment of advanced renal cell carcinoma.

Authors:  Daniele Alesini; Claudia Mosillo; Giuseppe Naso; Enrico Cortesi; Roberto Iacovelli
Journal:  Ther Adv Urol       Date:  2015-10

4.  One-year outcomes of a BioMime™ Sirolimus-Eluting Coronary Stent System with a biodegradable polymer in all-comers coronary artery disease patients: The meriT-3 study.

Authors:  Rajendra Kumar Jain; Padmanabha Chakravarthi; Rajan Shetty; Padmakumar Ramchandra; Raghava Sarma Polavarapu; Gurupreet Singh Wander; Bishav Mohan; Darshan Navinchandra Banker; Aniruddha Dharmadhikari; Shyam Sundar Bansal; Neeraj Jain; Dharmesh Solanki; Jagdish Dhakaan; Ved Prakash Sharma; Padhinhare P Mohanan; Parayaru Kottayal Ashokan; Bagur Venkat Manjunath; Narendra Hiregoudar; Chandrashekar Patil; Narasimha Balakrishnan
Journal:  Indian Heart J       Date:  2016-09-28

5.  Everolimus treatment in advanced solid tumors: a personal view.

Authors:  Sara Pusceddu; Alice Indini; Giuseppe Procopio
Journal:  Future Sci OA       Date:  2015-11-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.